case_images: PMC10757055_01
case_images: (A-F): 68Ga-PSMA PET/CT in a proven carcinoma prostate patient-maximum intensity projection image showing tracer avid lesions in the prostate, multiple skeletal lesions (skull, sternum, scapula, rib, multiple cervicodorsolumbar vertebrae, left iliac bone and right femur), mediastinal lymph nodes, fibro-consolidatory lesion in the lower lobe of the right lung and additional tracer uptake in nasal region (arrow) (a). Axial & coronal CT and corresponding fused PET/CT images of head showing physiological tracer uptake in the major and minor salivary glands, lacrimal glands with additional intense tracer uptake in the region of posterior pharynx likely in the tubarial salivary glands (arrows) (b-e). Anterior post-therapy whole-body image (post 177Lu PSMA-617 administration) showing tracer uptake in the tubarial salivary glands (arrow) and at other sites similar to the tracer distribution on 68Ga-PSMA PET/CT (f)
case_images: AOJNMB-12-43-g001.jpg
case_images: PMC10757055_01_AOJNMB-12-43-g001.jpg
case_images: F1
case_images: In addition to that, intense tracer uptake was noted in the region of posterior pharynx along with physiological tracer uptake in the major & minor salivary glands and lacrimal glands (Figure 1 a-e). PSMA-617 was administered to the patient under supervision after adequate hydration. Post therapy images demonstrated tracer uptake in the region of posterior nasopharynx and at other sites similar to the distribution on 68Ga-PSMA PET/CT (Figure 1 f).